Alpiropride (INNTooltip International Nonproprietary Name; brand name Revistel, Rivistel, or Rivestel) is a dopamine D₂ receptor antagonist of the benzamide group related to sulpiride. It is described as an antihypertensive agent and has been marketed for use as an antimigraine medication in Portugal. The drug was first described by 1980 and was introduced for medical use by 1989. It remained marketed in Portugal as late as 2000.